Contemporary issues in the diagnosis of parasitic infections

• 104 • Evaluation of nine commercial serological tests for the diagnosis of human hepatic cystic echinococcosis and the differential diagnosis with other focal liver lesions: a diagnostic accuracy study > S. Silvia Stefania LONGONI (Verona) • 1235 • Deep learning and microscopy: new perspectives in malaria diagnosis > R. Romualdo GRANDE (Milan) • 151 • Evaluation of microscopy, serology, circulating anodic antigen, and eosinophil counts for the follow-up of migrants with chronic schistosomiasis: a prospective cohort study > D. Dora BUONFRATE (Negrar Di Valpolicella) • 1687 • Acanthamoebic keratitis: 5-year study from a tertiary care eye centre in India > P. Prachala RATHOD (Delhi) • 1735 • A web-based platform for training and quality control of parasite microscopy > E. Egbert TANNICH (Hamburg) • 1841 • Evaluation of the Allplex^TM Gastrointestinal Panel - Helminth(I) Assay for the detection of helminths and microsporidia in stool samples > F. Florence ROBERT-GANGNEUX (Rennes) • 2101 • A microbiological diagnosis of cutaneous leishmaniasis in real-time PCR era: a five-year experience in a referral centre in Barcelona > A. Aroa SILGADO (Canovelles) • 222 • Genotypic and phylogenetic analysis of cutaneous leishmaniasis in Al Ahsa (Eastern Saudi Arabia) during COVID-19 crisis: first case of <em>Leishmania tropica</em> with predominance of <em>Leishmania major</em> > A. Abdullatif AL RASHED (Al Khobar) • 2515 • Evaluation of eosinophilic cationic protein as a biomarker of alveolar and cystic echinococcosis > H. Heimo LAGLER (Vienna) • 2692 • Prevalence of <em>Strongyloides</em> infection among steroid recipients in a tertiary care centre in North India > A. Aishwarya RAMPRASAD (New Delhi) • 2823 • Validation of a multiplex real-time PCR gastrointestinal parasite panel > M. Michelle ZHAO (Regina) • 3125 • Diagnostic performance and validation of a ready-to-use real-time PCR assay for the detection of <em>Leishmania</em> in human samples in comparison with three validated molecular methods > A. Albert ARNAU (Barcelona) • 3140 • Clinical validation of a new real-time PCR molecular assay for the detection of <em>Leishmania </em>spp. in both cutaneous and visceral clinical samples > C. Cristina ESCOLAR (Zaragoza) • 3190 • Screening versus single-pathogen detection when aiming for diagnosis of gastrointestinal infection caused by protist species > A. Alejandro DASHTI (Madrid) • 3243 • Bioinformatically informed peptide microarray for the development of a specific and sensitive test for the diagnosis of hepatic cystic echinococcosis > G. Gherard BATISTI BIFFIGNANDI (Pavia) • 4288 • Validation of a qPCR for differential and quantitative characterisation of the five human <em>Plasmodium</em>, including <em>P. knowlesi</em> > L. Lourdes BARÓN ARGOS (Madrid) • 4550 • Validation of a multiplex real-time PCR gastrointestinal helminth panel > K. Kimberley MARKS-BEAUBRUN (North York) • 703 • Screening of <em>Echinococcus granulosus</em> protoscolex antigens as novel candidates for the post-surgical follow-up of cystic echinococcosis in Tunisian paediatric patients > E. Eya BEN SALAH (Enfida) • 1473 • Serological diagnosis of toxoplasmosis: evaluation of available commercial IgG immunoblot test based on recombinant antigens on 142 characterised human sera > V. Vincent JEAN-PIERRE (Grenoble)